Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 6:40 AM UTC
| NCT Number | NCT06966700 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE3 |
| Target Enrollment | 2,400 participants |
| Active Locations | 64 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | October 13, 2026 (5 days ago) |
As of October 18, 2026: Clinical trial NCT06966700 is currently recruiting participants. This phase3 study for breast cancer is actively seeking new participants at 64 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06966700 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 64 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06966700 was last updated 5 days ago (October 13, 2026). HelloStudys verifies this status automatically.